BMI1 and ovarian carcinoma: In addition,isolated ovarian cancer stem cells exhibit much higher Bmi-1 levels compared to thedifferentiated or parental bulk tumor cells and have increased resistance tocisplatin and paclitaxel when compared to the tumor cells [23].